This same assay was further adopted by Chan et al. [41], who found significantly higher sE-cad concentrations in GC patients (nr = 116), correlating them with tumor size and carcinoembryonic antigen (CEA) amount. The gene discussed is CEACAM5; the disease is gastric cancer.